Grant: Discovery Grants Program - Individual
Université de Sherbrooke
$39,000.00
Biomimetic Materials and Bioprocesses for High-Density Cultures of Pancreatic Islets and Tissues
EF 2022-23
Résumé
3.5 million Canadians live with diabetes, with an associated cost of $ 3.4 billion. Beta-cells (cells producing insulin) lost has been observed in both types 1 and 2 diabetes. Pancreatic islet transplantation can restore functional beta-cells to achieve normoglycemia in type 1 diabetics. Islet transplantation has encountered problems including beta-cell apoptosis. Improving the success of islet transplantation has been a target in the research community. Also, the development of therapeutic to treat diabetes has been identified by pharmaceutical companies to be hindered due to a lack of adequate pancreatic tissue models. Tissue engineering methods have been applied to encapsulate and culture pancreatic islets and beta-cells in three-dimensional matrices, and using bioreactors. The aim here is to expose cells/tissues to environments mimicking their native ones, so they can behave more physiologically. Encapsulating pancreatic islets could be a solution to protect transplanted islets from host responses. Development in tissue engineering enables the use of decellularized organs and tissues as scaffolds for cell therapies. However, little is known about the mechanisms governing the effects of decellularized matrices on cells.The LONG-TERM PROGRAM OBJECTIVE is to develop the automated processes to isolate and culture endocrine pancreatic tissues and cells at high density and to adapt the process to other tissues and organs.The SPECIFIC OBJECTIVES are:1) To develop a perfusion bioreactor for organ/tissue decellularization and processes for cell/tissue seeding and culture. This reactor will be used to investigate pancreatic islets and beta-cells survival and function in decellularized organs and tissues under perfusion;2) To study endocrine pancreatic islets/cells survival and function on biomimetic surfaces produced from decellularized tissues/organs;3) To characterize the co-culture of endocrine pancreatic islets and cells with pancreatic microvessels under bioreactor perfusion.SIGNIFICANCE AND NOVELTY: 1) Our biomimetic surfaces provide excellent low-fouling coatings allowing studying specific cell responses by eliminating non-specific ones. 2) Knowledge about how biomimetic scaffolds affect islets can support the development of better encapsulation techniques. 3) Understanding how flow conditions affect islet responses allows identifying how transplanted islets are affected by physiological conditions at an implantation site. Developing an automated process to decellularize organs/tissues will be a step to transfer manually-operated laboratory-scale methods to industrial processes for cell therapy products. 4) Finally, little is known about how to re-establish a functional vasculature in isolated islets. We have been the first to isolate pancreatic microvessels. This program will support training of highly qualified personnel.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-06131
Name nom
Vermette, Patrick
Department département
Génie chimique et génie biotechnologique - Génie chimique et génie biotechnologique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
39000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Installment
inst:5
Partie
1
Nb partie
6
Application title
Biomimetic Materials and Bioprocesses for High-Density Cultures of Pancreatic Islets and Tissues
Application summary
3.5 million Canadians live with diabetes, with an associated cost of $ 3.4 billion. Beta-cells (cells producing insulin) lost has been observed in both types 1 and 2 diabetes. Pancreatic islet transplantation can restore functional beta-cells to achieve normoglycemia in type 1 diabetics. Islet transplantation has encountered problems including beta-cell apoptosis. Improving the success of islet transplantation has been a target in the research community. Also, the development of therapeutic to treat diabetes has been identified by pharmaceutical companies to be hindered due to a lack of adequate pancreatic tissue models. Tissue engineering methods have been applied to encapsulate and culture pancreatic islets and beta-cells in three-dimensional matrices, and using bioreactors. The aim here is to expose cells/tissues to environments mimicking their native ones, so they can behave more physiologically. Encapsulating pancreatic islets could be a solution to protect transplanted islets from host responses. Development in tissue engineering enables the use of decellularized organs and tissues as scaffolds for cell therapies. However, little is known about the mechanisms governing the effects of decellularized matrices on cells.The LONG-TERM PROGRAM OBJECTIVE is to develop the automated processes to isolate and culture endocrine pancreatic tissues and cells at high density and to adapt the process to other tissues and organs.The SPECIFIC OBJECTIVES are:1) To develop a perfusion bioreactor for organ/tissue decellularization and processes for cell/tissue seeding and culture. This reactor will be used to investigate pancreatic islets and beta-cells survival and function in decellularized organs and tissues under perfusion;2) To study endocrine pancreatic islets/cells survival and function on biomimetic surfaces produced from decellularized tissues/organs;3) To characterize the co-culture of endocrine pancreatic islets and cells with pancreatic microvessels under bioreactor perfusion.SIGNIFICANCE AND NOVELTY: 1) Our biomimetic surfaces provide excellent low-fouling coatings allowing studying specific cell responses by eliminating non-specific ones. 2) Knowledge about how biomimetic scaffolds affect islets can support the development of better encapsulation techniques. 3) Understanding how flow conditions affect islet responses allows identifying how transplanted islets are affected by physiological conditions at an implantation site. Developing an automated process to decellularize organs/tissues will be a step to transfer manually-operated laboratory-scale methods to industrial processes for cell therapy products. 4) Finally, little is known about how to re-establish a functional vasculature in isolated islets. We have been the first to isolate pancreatic microvessels. This program will support training of highly qualified personnel.